COMMUNIQUÉS West-GlobeNewswire

Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
21/09/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder [...]
R3 Vascular Appoints Lisa Wipperman Heine to its Board of Directors
21/09/2026
Brings more than three decades of experience leading innovation across the medical technology industry MOUNTAIN VIEW, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to [...]
Guardian Classic Welcomes Wounded Warrior Project as Official Sponsor Ahead of September 28 Charity Golf Tournament
21/09/2026
Two mission-driven nonprofit organizations team up to support active-duty, veterans, first responders and their families as the Guardian Classic enters its final days of registration and fundraising SAN DIEGO, Sept. 21 [...]
BayCare Releases 2025 Physician and Provider Annual Report
21/09/2026
CLEARWATER, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- BayCare Health System today released Vital Impact, its 2025 Physician and Provider Annual Report, highlighting a year of clinical excellence, academic growth and [...]
Acentra Health CEO Todd Stottlemyer Named to Virginia 500 Power List for Fifth Consecutive Year
21/09/2026
Recognition underscores the healthcare technology leader’s sustained commitment to Virginia’s business community and improved health outcomes nationwide MCLEAN, Va., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a [...]
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
21/09/2026
Investment was led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million registered direct [...]
KFSH Recognized in Newsweek’s World’s Best Specialized Hospitals 2027
21/09/2026
RIYADH, Saudi Arabia, Sept. 21, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) has reinforced its position as a global healthcare leader, earning prominent placement in Newsweek’s [...]
NeOnc Charting New Nasal Route to Treating Brain Cancer
21/09/2026
DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – NeOnc Technologies Holdings’ (NASDAQ: NTHI) NEO100 deserves attention; not just because its Phase 2a study has suddenly solved brain cancer, but because [...]
Hoag Hospital Irvine Sun Family Campus Now Open, Introducing a New Model for Specialized Care in Orange County
21/09/2026
Six-Building Expansion Brings Specialized Hospital and Outpatient Care Together on One Integrated Campus Dedicated Cancer, Women’s Health, Digestive Health and Surgical Facilities Expand Access to Advanced Care in [...]
Microdose Tirzepatide: New Study Reports 4.4- to 6.9-Pound Average Weight Loss by Day 59
21/09/2026
Retrospective analysis of 60 adults on compounded tirzepatide, 1–2 mg weekly: 4.4 lb average among 57 at days 14–35, 6.9 lb among 19 at days 36–59; not peer reviewed ALPHARETTA, Ga., Sept. 21, 2026 (GLOBE NEWSWIRE) -- A [...]
Change to American Depositary Share Ratio
21/09/2026
SYDNEY, AUSTRALIA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces a [...]
HealthLynked Announces Strategic Enterprise Pilot with Palm Beach Accountable Care Organization to Advance AI-Powered Patient Engagement and Value-Based Care
21/09/2026
NAPLES, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a healthcare technology company focused on AI-powered patient engagement and care coordination, today announced a strategic [...]
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
21/09/2026
Poster presentations further characterize clinical profile of HLP003 and Phase 3 PARADIGM program evaluating HLP003 as a potential adjunctive treatment for major depressive disorder (“MDD”) NEW YORK and TORONTO, Sept. [...]
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
21/09/2026
Decision advances Company’s previously announced capital-efficient development strategy by concentrating resources on FDA-authorized, SKNJCT-005, NDA-enabling, Registrational Phase 2b Study in Gorlin syndrome patients [...]
InflaRx to Host Virtual Capital Markets Day
21/09/2026
Event to be hosted on November 3, 2026 at 8:00 AM EST Featured speakers will include Peter A. Merkel, MD, MPH and Prof. Dr. Jörg Köhl Jena, Germany, Sept. 21, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a [...]
Dr. Maximilian Doebler appointed Chief Executive Officer of HMNC Brain Health as Company moves into next phase of global growth
21/09/2026
HMNC recently closed a $50 million Series B financing and a European commercialization partnership with MEDICE for its Ketabon program Doebler has helped shape HMNC's development since 2019, most recently as Managing [...]
Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
21/09/2026
VISTA met its FDA-endorsed primary endpoint, demonstrating statistically significant low luminance visual acuity (LLVA) responder rates at Month 12 compared to the untreated control group A statistically significant [...]
Vironexis Announces Complete and Durable Responses in Relapsed/Refractory ALL Patients Treated with VNX-101
21/09/2026
In the ongoing SENTRY-CD19 trial, all three anti-AAV antibody-naïve patients with relapsed/refractory acute lymphoblastic leukemia (ALL) have achieved MRD-negative complete responses following a single administration of [...]
Seer Announces CFO Transition
21/09/2026
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the [...]

Pages